PPARA and hyperlipidemia: However, some clinical reports found the direct uptake of PPARα-enhancing drug, Fenofibrate (Downlip®, 200 mg, 1 tablet per day), for controlling hyperlipidemia may have side-effects in skin to cause photoallergen with basal vacuolation and superficial perivascular inflammation47.